Heterocyclic Organobismuth(III) Compound Targets Tubulin to Induce G2/M Arrest in HeLa Cells
Our previous study showed that organobismuth compounds induce apoptosis in human promyelocytic leukemia cells, although solid tumor cell lines were relatively resistant. Herein, we investigated the primary cellular target of these compounds in HeLa cells. One organobismuth compound, bi-chlorodibenzo...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S134786131931240X |
id |
doaj-b7be0e5507104197887a7fe30edbc17b |
---|---|
record_format |
Article |
spelling |
doaj-b7be0e5507104197887a7fe30edbc17b2020-11-25T02:15:02ZengElsevierJournal of Pharmacological Sciences1347-86132009-01-011094573582Heterocyclic Organobismuth(III) Compound Targets Tubulin to Induce G2/M Arrest in HeLa CellsKatsuya Iuchi0Kiwamu Akagi1Tatsuo Yagura2Department of Bioscience, Faculty of Science and Technology, Kwansei Gakuin University, 2-1, Gakuen, Sanda 669-1337, JapanDivision of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, 818 Komuro, Ina-machi, Kitaadachi-gun, Saitama 362-0806, JapanDepartment of Bioscience, Faculty of Science and Technology, Kwansei Gakuin University, 2-1, Gakuen, Sanda 669-1337, Japan; Corresponding author. tyagura@kwansei.ac.jpOur previous study showed that organobismuth compounds induce apoptosis in human promyelocytic leukemia cells, although solid tumor cell lines were relatively resistant. Herein, we investigated the primary cellular target of these compounds in HeLa cells. One organobismuth compound, bi-chlorodibenzo[c,f][1,5]thiabismocine (compound 3), arrested the cell cycle at G2/M as assessed by flow cytometry and by upregulating the expression of cyclin B1. At a low concentration (0.5 μM), compound 3 caused cell cycle arrest at the mitotic phase and induced apoptosis. At a higher concentration (>1.0 μM), it induced an arrest in the G2/M phase, leading to apoptosis. In many cells blocked at the M phase, the organization of microtubules was affected, indicating depolymerization of the microtubule network. Western blotting demonstrated that compound 3 depolymerized microtubules similar to colchicine and nocodazole. Experiments in vitro also showed that compound 3 inhibited the assembly of purified tubulin in a concentration-dependent manner by interacting with the colchicine-binding site of tubulin through its SH groups. Heterocyclic organobismuth compounds are novel tubulin ligands. Keywords:: bismuth, tubulin, cell death, mitotic arrest, anticancerhttp://www.sciencedirect.com/science/article/pii/S134786131931240X |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Katsuya Iuchi Kiwamu Akagi Tatsuo Yagura |
spellingShingle |
Katsuya Iuchi Kiwamu Akagi Tatsuo Yagura Heterocyclic Organobismuth(III) Compound Targets Tubulin to Induce G2/M Arrest in HeLa Cells Journal of Pharmacological Sciences |
author_facet |
Katsuya Iuchi Kiwamu Akagi Tatsuo Yagura |
author_sort |
Katsuya Iuchi |
title |
Heterocyclic Organobismuth(III) Compound Targets Tubulin to Induce G2/M Arrest in HeLa Cells |
title_short |
Heterocyclic Organobismuth(III) Compound Targets Tubulin to Induce G2/M Arrest in HeLa Cells |
title_full |
Heterocyclic Organobismuth(III) Compound Targets Tubulin to Induce G2/M Arrest in HeLa Cells |
title_fullStr |
Heterocyclic Organobismuth(III) Compound Targets Tubulin to Induce G2/M Arrest in HeLa Cells |
title_full_unstemmed |
Heterocyclic Organobismuth(III) Compound Targets Tubulin to Induce G2/M Arrest in HeLa Cells |
title_sort |
heterocyclic organobismuth(iii) compound targets tubulin to induce g2/m arrest in hela cells |
publisher |
Elsevier |
series |
Journal of Pharmacological Sciences |
issn |
1347-8613 |
publishDate |
2009-01-01 |
description |
Our previous study showed that organobismuth compounds induce apoptosis in human promyelocytic leukemia cells, although solid tumor cell lines were relatively resistant. Herein, we investigated the primary cellular target of these compounds in HeLa cells. One organobismuth compound, bi-chlorodibenzo[c,f][1,5]thiabismocine (compound 3), arrested the cell cycle at G2/M as assessed by flow cytometry and by upregulating the expression of cyclin B1. At a low concentration (0.5 μM), compound 3 caused cell cycle arrest at the mitotic phase and induced apoptosis. At a higher concentration (>1.0 μM), it induced an arrest in the G2/M phase, leading to apoptosis. In many cells blocked at the M phase, the organization of microtubules was affected, indicating depolymerization of the microtubule network. Western blotting demonstrated that compound 3 depolymerized microtubules similar to colchicine and nocodazole. Experiments in vitro also showed that compound 3 inhibited the assembly of purified tubulin in a concentration-dependent manner by interacting with the colchicine-binding site of tubulin through its SH groups. Heterocyclic organobismuth compounds are novel tubulin ligands. Keywords:: bismuth, tubulin, cell death, mitotic arrest, anticancer |
url |
http://www.sciencedirect.com/science/article/pii/S134786131931240X |
work_keys_str_mv |
AT katsuyaiuchi heterocyclicorganobismuthiiicompoundtargetstubulintoinduceg2marrestinhelacells AT kiwamuakagi heterocyclicorganobismuthiiicompoundtargetstubulintoinduceg2marrestinhelacells AT tatsuoyagura heterocyclicorganobismuthiiicompoundtargetstubulintoinduceg2marrestinhelacells |
_version_ |
1724898237903536128 |